TheChek News Flow

BUS 11/17 07:53 Pfizer Forms Global Strategic Alliance with Merck KGaA, Germany, to Jointly Develop and Commercialize Anti-PD-L1 to Accelerate
BFW 11/17 07:56 *PFIZER MAINTAINS OTHER ELEMENTS OF 2014 FORECAST
BN 11/17 07:56 *PFIZER CUTS FY REPORTED EPS VIEW TO $1.40-$1.49 VS $1.50-$1.59
BFW 11/17 07:54 *PFIZER CUTS EPS GUIDANCE RANGE TO $1.40-$1.49 FROM $1.50-$1.59
BN 11/17 07:54 *PFIZER MAINTAINING OTHER ELEMENTS OF '14 FINL GUIDANCE
BN 11/17 07:53 *PFIZER UPDATING '14 REPORTED EPS GUIDANCE RANGE TO $1.40-$1.49
BN 11/17 07:53 *PFIZER UPDATES '14 REPORTED EPS RANGE
BN 11/17 07:53 *PFIZER FORMS GLOBAL ALLIANCE W/ MERCK KGAA, GERMANY, TO JOINTLY

Pfizer Cuts 2014 Reported Diluted EPS Range to $1.40-$1.49
2014-11-17 07:56:37.786 GMT


By Allison Connolly
Nov. 17 (Bloomberg) -- Co. updates previous 2014 reported
diluted EPS guidance range to $1.40-$1.49 vs $1.50-$1.59 after
deal with Merck KGaA.
* Co. keeps rest of 2014 guidance
* NOTE: Earlier, Merck KGaA, Pfizer to Commercialize Immuno-
Oncology Asset {NSN NF6B8P6JIJV0 <go>}

Link to Statement:{NSN NF6B8CMEQTXC <GO>}
Link to Company News:{MRK GR <Equity> CN <GO>}
Link to Company News:{PFE US <Equity> CN <GO>}

For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}

To contact the reporter on this story:
Allison Connolly in London at +44-20-3525-7043 or
aconnolly4@bloomberg.net

To contact the editor responsible for this story:
Allison Connolly at +44-20-3525-7043 or
aconnolly4@bloomberg.net